Comprehensive analysis of Bank of India Multi Cap Fund - Direct (IDCW) (43789) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Bank of India Investment Managers Private Ltd
The investment objective of the scheme is to generate long term capital appreciation by investing in equity and equity-related securities across various market capitalisation. However, there can be no assurance that the investment objectives of the Scheme will be realized.
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Weak Returns
High Risk
Low Expense Ratio
Equity Focused
Established Team
Average Quality
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Historical performance consistency
Outperformance vs benchmark
Market exposure level
Fund management costs
Recent performance momentum
Fund manager experience
Risk-adjusted returns
Assets under management
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| HDFC Bank Ltd | Banks | 5.50% |
| Reliance Industries Ltd | Refineries | 4.43% |
| TREPS | Debt Others | 3.63% |
| Lloyds Metals & Energy Ltd | Mining & Mineral products | 3.59% |
| ERIS Lifesciences Ltd | Pharmaceuticals | 3.10% |
| Hero MotoCorp Ltd | Automobile | 2.98% |
| Manorama Industries Ltd | FMCG | 2.90% |
| ICICI Lombard General Insurance Company Ltd | Insurance | 2.84% |
| PB Fintech Ltd | IT - Software | 2.66% |
| Acutaas Chemicals Ltd | Pharmaceuticals | 2.40% |
Compare against Multi Cap Fund category average
This comparison shows how the fund performs relative to the Multi Cap Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Multi Cap Fund category
| Fund Name | NAV | 3M | 6M | 1Y |
|---|---|---|---|---|
| ICICI Pru Multicap Fund - Direct (G) | ₹876.90 | 0.83% | 14.97% | -2.69% |
| ICICI Pru Multicap Fund - (G) | ₹785.02 | 0.63% | 14.51% | -3.46% |
| Quant Multi Cap Fund - Direct (G) | ₹662.02 | -1.38% | 13.06% | -14.66% |
| Quant Multi Cap Fund (G) | ₹606.49 | -1.66% | 12.41% | -15.64% |
| Sundaram Multi Cap Fund - Direct (G) | ₹424.58 | 3.16% | 18.12% | -0.22% |
| Sundaram Multi Cap Fund (G) | ₹380.88 | 2.89% | 17.50% | -1.27% |
| Nippon India Multi Cap Fund - Direct (G) | ₹329.10 | 2.41% | 20.40% | 1.07% |
| Nippon India Multi Cap Fund - Direct (B) | ₹329.10 | 2.41% | 20.40% | 1.07% |
| Baroda BNP Paribas Multi Cap Fund-Dir (G) | ₹320.60 | 2.56% | 16.86% | -1.21% |
| Nippon India Multi Cap Fund (G) | ₹299.62 | 2.20% | 19.92% | 0.26% |
A seasoned investment professional with over 3 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.